Bagai Shaun 4
4 · RenovoRx, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Bagai Shaun
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-05-19$2.05/sh+5,500$11,275→ 251,557 total
Footnotes (1)
- [F1]Includes 246,057 shares previously reported on a Form 3 filed on August 25, 2021 as a fully vested stock option exercisable at $0.15 per share. The option was exercised in full prior to the Issuer's initial public offering.